EAGEN, Minn.Immune health company Biothera has partnered with Ortho Molecular Products to debut Biothera's Wellmune WGP® in the healthcare professional market. Ortho Molecular Products launched its WholeMune capsules containing Wellmune, including a 10-count blister pack.
Biothera is a respected leader in immune research and we are excited to partner with them," said Aaron Bartz, president of Ortho Molecular Products. "Wellmunes extensive clinical research underscores its effectiveness and meets our demand for ingredients that have proven resultsbecause we are committed to providing efficacious products that get patients better faster."
WholeMune contains the recommended 250 mg of Wellmune, a proprietary strain of baker's yeast. The 1,3/1,6 beta glucan is clinically proven to maintain health during the cold and flu season.